trigram

This is a table of type trigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.

trigram	frequency
stem cell transplantation	1488
as well as	1348
in patients with	1179
the presence of	1010
cd t cells	981
the use of	937
the number of	855
in order to	782
hematopoietic stem cell	688
a total of	628
the development of	613
cd t cell	570
of the patients	569
in this study	566
of patients with	528
conflict of interest	524
of this study	493
the risk of	485
background case studies	481
one of the	480
of conflict of	479
disclosure of conflict	479
the aim of	469
study was to	455
the role of	452
mhc class i	451
the incidence of	445
is associated with	427
due to the	425
cd and cd	421
according to the	410
based on the	410
to evaluate the	391
study design method	387
the time of	387
there was no	385
with a median	384
the effect of	382
this study was	381
for patients with	379
allogeneic stem cell	373
to determine the	370
the expression of	363
in the presence	352
red blood cells	344
at the time	343
the majority of	340
of the study	339
the absence of	338
aim of this	325
was associated with	324
the treatment of	317
nothing to declare	316
allogeneic hematopoietic stem	315
a median of	314
compared to the	310
was used to	309
the most common	309
hla class i	306
the impact of	302
found to be	299
the frequency of	293
associated with a	292
was observed in	285
a median follow	285
t cell responses	283
red blood cell	276
cumulative incidence of	270
peripheral blood stem	267
cells in the	266
as compared to	262
the outcome of	256
in terms of	256
by flow cytometry	253
aim of the	253
in the first	253
t cells in	252
in addition to	251
it has been	248
there were no	244
t cell epitopes	242
the results of	242
been shown to	241
patients who received	241
role in the	240
to assess the	239
versus host disease	238
graft versus host	238
mhc class ii	236
there is a	236
a number of	236
there was a	235
in response to	229
well as the	229
at a median	227
we found that	225
were treated with	224
bone marrow transplantation	222
median age was	218
of t cell	214
and in the	214
autologous stem cell	213
specific cd t	213
associated with the	211
in the absence	211
to investigate the	211
analysis of the	210
the immune system	209
of cd t	207
of the blood	207
the median age	206
was found to	206
of the disease	205
morbidity and mortality	204
t cells were	204
the quality of	204
median age of	203
and cd t	202
in patients who	200
the need for	199
t cells and	198
of blood components	198
involved in the	197
the percentage of	196
in all patients	195
included in the	192
the prevalence of	191
before and after	190
of t cells	187
an increase in	187
median time to	187
the most frequent	186
at least one	186
major histocompatibility complex	186
the end of	185
in both groups	185
class i molecules	184
acute myeloid leukemia	184
has been shown	184
were used to	183
stem cell transplant	183
the production of	182
in the study	182
the efficacy of	180
the level of	180
the t cell	179
of cd cells	178
there is no	177
t cell receptor	177
the detection of	174
was performed using	174
patients with a	173
of the immune	173
has not been	173
were included in	172
to be a	172
of blood donors	171
no significant difference	171
is the most	170
the median time	170
of blood products	170
be associated with	169
were associated with	169
the context of	169
stem cell source	168
study is to	168
can be used	168
severe acute respiratory	166
was performed by	166
the induction of	165
in combination with	164
most of the	164
acute respiratory syndrome	164
the rate of	164
weak d type	164
in the context	163
are associated with	163
the importance of	163
reduced intensity conditioning	163
because of the	162
shown to be	162
be used to	162
the immune response	162
increase in the	161
the identification of	161
between the two	161
median follow up	160
data suggest that	159
blood stem cell	159
blood stem cells	159
risk factors for	158
to reduce the	157
the pathogenesis of	157
part of the	157
of patients who	156
expression of the	155
as a result	155
all patients received	155
with or without	155
the present study	155
in case of	154
of these patients	154
age was years	154
umbilical cord blood	154
the diagnosis of	153
the lack of	153
class i and	153
the blood bank	153
median age at	153
was significantly higher	151
was found in	151
patients in the	150
was performed in	150
patients who underwent	149
the conditioning regimen	149
this study is	149
is one of	149
on the other	149
hematopoietic cell transplantation	148
of the hla	148
was detected in	147
t cell response	146
all patients were	146
the effects of	146
an important role	145
the ability of	145
in of patients	145
has been reported	145
none of the	145
have been reported	144
the course of	144
memory t cells	143
specific t cells	143
up of months	142
in the treatment	142
results suggest that	141
of the most	141
significantly higher in	141
related to the	141
were detected in	141
in children with	141
blood and blood	141
the purpose of	140
median number of	140
with respect to	140
t cell clones	140
total number of	139
of blood transfusion	139
of the patient	139
the ability to	139
have shown that	139
mg kg day	139
significant difference in	139
when compared to	139
patients treated with	139
hla class ii	138
study design methods	138
quality of life	138
important role in	137
and chronic gvhd	136
in the blood	136
the two groups	135
for the treatment	135
patients with severe	135
the other hand	134
acute and chronic	134
was defined as	133
median time of	133
were able to	133
of acute gvhd	132
total of patients	132
a and b	132
the implementation of	132
after a median	131
was used for	131
in comparison to	131
were found in	131
to study the	130
the proportion of	130
were found to	130
human leukocyte antigen	129
of whole blood	129
from patients with	129
in of the	129
for the first	129
in contrast to	128
the addition of	128
was determined by	127
the activation of	127
is based on	127
the study was	127
in these patients	126
in the last	125
years of age	125
the control group	125
patients who had	124
during the first	124
the surface of	124
number of patients	124
patients with acute	124
the cumulative incidence	123
used as a	123
present in the	122
used in the	122
the case of	122
was carried out	122
a combination of	122
t cells from	122
risk factor for	122
a result of	122
high levels of	122
to identify the	122
in the control	121
was to evaluate	121
of mhc class	121
appears to be	120
follow up of	120
are needed to	120
the patient was	120
of the cd	120
showed that the	120
haematopoietic stem cell	120
acute lymphoblastic leukemia	120
a role in	119
immune response to	119
number of cd	119
a variety of	119
we conclude that	118
the amount of	118
resulted in a	118
t cell activation	118
due to a	117
the patients with	117
seems to be	117
in our study	117
expression of cd	117
differences in the	117
of the sars	116
the fact that	116
the generation of	116
the basis of	116
no significant differences	116
in peripheral blood	116
in blood donors	116
were tested for	116
were observed in	115
t cells are	115
increased risk of	114
of blood and	114
analysis was performed	114
the introduction of	114
cell transplantation in	113
was used in	113
the occurrence of	113
the patients who	113
a panel of	113
found in the	112
with a high	112
the age of	112
and overall survival	111
significantly associated with	111
suggest that the	111
at time of	111
as part of	111
group of patients	110
specific t cell	110
in the group	110
we investigated the	110
regulatory t cells	109
an average of	109
used for the	109
at the end	108
at room temperature	108
for the development	108
cytotoxic t lymphocytes	108
could not be	108
was seen in	108
in all cases	107
the management of	107
out of patients	107
in our center	107
in transfusion medicine	107
the most important	107
blood transfusion service	106
of patients were	106
a decrease in	106
the safety of	106
hematopoietic stem cells	106
median of days	106
in vitro and	105
associated with increased	105
on the surface	105
in the present	105
at our institution	105
to analyze the	105
of red blood	105
we analyzed the	105
a patient with	105
were used for	105
the total number	104
after allogeneic hematopoietic	104
been associated with	104
in patients undergoing	104
conditioning regimen was	103
of cd and	103
total body irradiation	103
at the same	103
in the same	103
for the detection	103
in the number	103
the objective of	102
a median age	102
each of the	102
observed in the	102
human immunodeficiency virus	102
was performed on	102
and bone marrow	101
contribute to the	101
the cell surface	101
age of years	101
was significantly lower	101
to compare the	100
the levels of	100
t cell epitope	100
and safety of	100
in the pathogenesis	100
is characterized by	100
incidence of relapse	99
between january and	99
the type of	99
of our study	99
and of the	99
year overall survival	99
is the first	99
patients with high	99
be due to	99
difference in the	99
this is a	99
in complete remission	98
of stem cells	98
in the development	98
were performed in	98
shown in table	98
patients received a	98
the setting of	97
majority of patients	97
of the t	97
may be a	97
results of the	97
of hla class	97
we show that	97
sickle cell disease	97
on the basis	97
blood samples were	96
in the setting	96
compared with the	96
use of the	96
derived from the	96
was used as	96
cohort of patients	96
this study we	96
have been shown	96
in multivariate analysis	95
end of the	95
detected in the	95
to have a	95
results indicate that	95
in the case	94
not associated with	94
should be considered	94
such as the	94
of the donor	94
some of the	94
the analysis of	94
did not differ	94
a median time	94
the mhc class	93
depending on the	93
the possibility of	93
this is the	93
iv acute gvhd	93
no difference in	93
in out of	93
was assessed by	92
incidence of acute	92
are shown in	92
play a role	92
on day and	92
of the total	91
matched unrelated donor	91
their ability to	91
to determine whether	91
to improve the	91
understanding of the	91
gd t cells	91
fresh frozen plasma	91
in the early	91
the same time	91
the severity of	91
to be associated	90
were used as	90
class ii molecules	90
prior to the	90
were obtained from	90
more likely to	90
known to be	90
to be the	90
higher in the	90
patients who were	90
a group of	90
t cells with	90
who did not	90
i and ii	90
after allogeneic stem	90
the combination of	89
the onset of	89
in a single	89
the distribution of	89
we observed a	89
the median follow	89
is an important	89
patients with aml	89
are able to	89
the patients were	89
memory cd t	89
significant differences in	89
in comparison with	89
safety and efficacy	88
it is not	88
a series of	88
peripheral blood mononuclear	88
need to be	88
were collected from	88
that can be	88
to increase the	88
the last years	88
d and d	88
the availability of	87
has also been	87
associated with an	87
patients were treated	87
was higher in	87
of peripheral blood	87
neutrophil and platelet	87
the first time	87
of the donors	87
influenza a virus	86
purpose of this	86
compared to those	86
but not in	86
was performed with	86
a history of	86
objective of this	86
of nk cells	86
safe and effective	85
of the human	85
cell responses to	85
response to the	85
these results suggest	85
blood mononuclear cells	85
of the virus	85
patients had a	85
was no significant	85
than in the	84
the association of	84
a retrospective study	84
we report the	84
in the table	84
in the future	84
the regulation of	84
one or more	84
t cell proliferation	84
blood group system	84
can lead to	84
is a major	84
of the peptide	84
we performed a	84
of the first	84
of chronic gvhd	84
of bone marrow	84
the duration of	83
blood donors in	83
occurred in patients	83
balb c mice	83
in t cell	83
and in vivo	83
of them were	83
it is possible	83
of blood donation	83
is a rare	82
these data suggest	82
cell transplantation for	82
well as in	82
were analyzed by	82
central nervous system	82
high risk of	82
evaluation of the	82
obtained from the	82
a subset of	82
development of a	82
results show that	82
were used in	82
the first year	82
a cohort of	82
as shown in	82
use of blood	81
be involved in	81
was no difference	81
studies have shown	81
the day of	81
blood donors and	81
all patients had	81
we hypothesized that	81
may lead to	81
after the first	81
and patients with	81
and it is	81
allogeneic hematopoietic cell	81
to determine if	81
activation of the	80
the united states	80
difference between the	80
males and females	80
toxic epidermal necrolysis	80
acute gvhd was	80
we evaluated the	80
the bone marrow	80
p disclosure of	80
the specificity of	80
any of the	80
all of the	80
and blood products	79
was the most	79
the potential to	79
the peripheral blood	79
systemic lupus erythematosus	79
to the development	79
the degree of	79
majority of the	79
retrospective analysis of	79
more than one	79
large number of	79
chronic gvhd was	79
responsible for the	79
show that the	79
and t cell	79
in a patient	78
patients were included	78
of the cases	78
likely to be	78
indicate that the	78
half of the	78
have not been	78
the process of	78
median duration of	78
differences between the	77
specificity of the	77
the first days	77
in the second	77
out of the	77
were positive for	77
the safety and	77
impact on the	77
of the same	77
respiratory syndrome coronavirus	77
reduce the risk	77
play an important	77
was performed to	76
we observed that	76
a dose of	76
a range of	76
in cases of	76
observed in patients	76
within the first	76
in accordance with	76
we aimed to	76
in patients receiving	76
in a large	76
the effectiveness of	76
with and without	76
antigen presenting cells	76
from the same	76
the study of	75
the goal of	75
the group of	75
the control of	75
the loss of	75
disease of the	75
to patients with	75
full donor chimerism	75
role of the	75
are involved in	75
was treated with	75
the cd t	75
quality of the	75
effect on the	75
t and b	75
in pts with	75
the probability of	75
and efficacy of	75
of transfusion medicine	74
risk of relapse	74
patients are alive	74
may contribute to	74
compared to patients	74
all of them	74
in patients and	74
cells of the	74
for up to	74
been reported to	74
and class ii	74
patients and methods	74
significantly lower in	74
has to be	74
is the only	74
we retrospectively analyzed	74
the influence of	74
for treatment of	73
age of the	73
in the two	73
were carried out	73
changes in the	73
a reduction in	73
all the patients	73
the study period	73
histocompatibility complex class	73
data indicate that	73
between the groups	73
patients suffering from	73
of patients and	73
with multiple myeloma	73
presence of a	73
be used for	73
for the presence	73
the prevention of	72
have been described	72
be able to	72
was able to	72
material and methods	72
died due to	72
we have previously	72
appear to be	72
median time from	72
the median number	72
vitro and in	72
immune responses to	72
cord blood transplantation	72
of cd cd	72
is important to	72
is an effective	72
up to days	71
higher risk of	71
samples were collected	71
can also be	71
bone marrow transplant	71
a retrospective analysis	71
acute gvhd grade	71
has been used	71
were performed using	71
during the study	71
at years was	71
hepatitis b virus	71
studies are needed	71
in association with	71
found that the	71
patients with multiple	71
and the other	71
needs to be	71
at our center	70
and platelet engraftment	70
in some cases	70
we conducted a	70
has been found	70
significant increase in	70
cause of death	70
in the literature	70
compared to controls	70
in pediatric patients	70
it is important	70
and for the	70
for all patients	70
transplant related mortality	70
included in this	70
samples were tested	70
t cells was	70
myeloablative conditioning regimen	70
minimal residual disease	70
was measured by	70
in the united	70
to that of	70
of red cell	70
patients were transplanted	70
levels of il	69
structure of the	69
as a consequence	69
in which the	69
we did not	69
was present in	69
direct antiglobulin test	69
disclosure of interest	69
of stem cell	69
considered to be	69
from january to	69
in recent years	69
of the mhc	69
there are no	68
higher incidence of	68
identified in the	68
hiv infected cells	68
the general population	68
was achieved in	68
cd cd cd	68
time to neutrophil	68
hepatitis c virus	68
were no significant	68
based on a	68
to declare background	68
the cause of	68
of all patients	68
was confirmed by	68
performed using the	68
were significantly higher	68
patients who have	68
the relationship between	67
overall survival was	67
there is an	67
the formation of	67
the administration of	67
from whole blood	67
was to determine	67
the overall survival	67
associated with higher	67
aim was to	67
in the past	67
a significant increase	66
t h e	66
the outcomes of	66
with regard to	66
factors associated with	66
the application of	66
for at least	66
identification of the	66
adult patients with	66
which can be	66
are the most	66
is known to	66
in relation to	66
with high risk	66
t cells to	65
materials and methods	65
by means of	65
the hypothesis that	65
school of medicine	65
remains to be	65
been found to	65
have been used	65
in this case	65
a period of	65
blood transfusion services	65
have been identified	65
is essential for	65
the function of	65
of the two	65
from diagnosis to	65
of the tcr	64
intensive care unit	64
our study was	64
the release of	64
t cells that	64
be considered as	64
outcome of patients	64
the mechanism of	64
is necessary to	64
in whole blood	64
may not be	64
with the use	64
that of the	64
the emergence of	64
did not have	64
implementation of the	63
more than of	63
in the serum	63
led to the	63
is due to	63
in one patient	63
been used to	63
dose of mg	63
cd cells were	63
will be presented	63
lead to a	63
the first months	63
all patients with	63
the patient and	63
the s protein	63
polymerase chain reaction	63
we were able	63
here we report	63
innate and adaptive	63
disease status at	63
the blood transfusion	63
resulting in a	62
suggesting that the	62
were determined by	62
were divided into	62
b cells and	62
the cost of	62
a t cell	62
is required for	62
correlation between the	62
an increased risk	62
no evidence of	62
a case of	62
source of stem	62
and b cells	62
reported to be	62
at day and	62
of allogeneic hematopoietic	62
was shown to	61
the concentration of	61
the only curative	61
for more than	61
of patients had	61
been reported in	61
the performance of	61
of the skin	61
lead to the	61
patients were in	61
no statistically significant	61
were compared to	61
b and c	61
of at least	61
the period of	61
leading to the	61
and it was	61
the design of	61
samples were taken	61
prophylaxis consisted of	61
we report a	61
not statistically significant	61
but it is	60
e and e	60
surface expression of	60
this retrospective study	60
significant differences between	60
suggests that the	60
have to be	60
we found a	60
on the cell	60
cytotoxic t lymphocyte	60
that there is	60
flow cytometry and	60
control of the	60
statistically significant difference	60
causes of death	60
the association between	60
is the author	60
is involved in	60
for patients who	60
consistent with the	60
age at transplant	60
not significantly different	60
cd cells kg	60
to display the	60
the binding of	60
of hematopoietic stem	60
proportion of patients	60
performed in the	60
a lack of	60
lung transplant recipients	60
be used as	60
members of the	60
or absence of	60
the results were	60
case of a	59
for the patients	59
was diagnosed in	59
acute graft versus	59
member of the	59
as gvhd prophylaxis	59
based on these	59
was to assess	59
in the majority	59
of patients in	59
carried out in	59
a license to	59
preprint in perpetuity	59
display the preprint	59
the response to	59
extensive chronic gvhd	59
added to the	59
and the number	59
in of cases	59
expression of hla	59
immune response in	59
of acute rejection	59
an immune response	59
has granted medrxiv	59
as previously described	59
no differences in	59
and can be	59
data not shown	59
weak d types	59
followed by a	59
license to display	59
efficacy and safety	59
granted medrxiv a	59
study was conducted	59
critically ill patients	59
it can be	59
the author funder	59
medrxiv a license	59
who has granted	59
i and class	59
the preprint in	59
a significantly higher	58
the selection of	58
could be used	58
addition to the	58
to predict the	58
is caused by	58
significant difference between	58
bone marrow and	58
of the population	58
which may be	58
clinical and laboratory	58
median age years	58
and mycophenolate mofetil	58
whole blood and	58
a significant reduction	58
and cd cells	58
is possible to	58
safety of blood	58
data show that	58
to bind to	58
were detected by	58
are summarized in	58
little is known	58
is able to	58
no effect on	58
was to investigate	58
cells from the	58
were isolated from	58
data on the	58
major cause of	57
is a common	57
severe combined immunodeficiency	57
tumor necrosis factor	57
to confirm the	57
to examine the	57
in line with	57
during the last	57
acute or chronic	57
according to our	57
number of blood	57
a single center	57
an increase of	57
day and day	57
similar to the	57
the blood supply	57
our data suggest	57
one of these	57
the patient is	57
aim of our	57
decrease in the	57
days after the	57
to define the	56
regions of the	56
the stem cell	56
a set of	56
and may be	56
significantly higher than	56
it may be	56
among patients with	56
and quality of	56
of the drug	56
has led to	56
in all the	56
of the major	56
a large number	56
use of a	56
to understand the	56
antibodies were detected	56
in the patients	56
on the day	56
was supported by	56
and did not	56
in children and	56
blood donors are	56
in humanized mice	56
assessment of the	56
in the us	56
region of the	56
of severe acute	56
specific for the	56
could be a	55
were diagnosed with	55
effect of the	55
bone marrow failure	55
it was found	55
have been developed	55
demonstrated that the	55
male and female	55
be related to	55
sensitivity and specificity	55
has been associated	55
unrelated cord blood	55
donor and recipient	55
who received a	55
mutations in the	55
lower in the	55
to the blood	55
located in the	55
seem to be	55
the activity of	55
defined as the	55
the in vitro	55
with the same	55
the copyright holder	55
in our hospital	55
cell source was	55
and blood components	55
the cells were	55
analyses were performed	55
of the cells	55
high level of	54
nature of the	54
small number of	54
the potential for	54
b cell epitopes	54
severe aplastic anemia	54
presence or absence	54
up to of	54
the feasibility of	54
acute lung injury	54
did not show	54
and the median	54
led to a	54
ranged from to	54
is known about	54
patients with chronic	54
or chronic gvhd	54
cd cell dose	54
we have developed	54
reduction of the	54
further studies are	54
of the graft	54
performance of the	54
summarized in table	54
cytotoxic t cells	54
the capacity of	53
proved to be	53
in spite of	53
and peripheral blood	53
c bl mice	53
patients who are	53
from healthy donors	53
after days of	53
in the immune	53
and at the	53
n a l	53
in the other	53
risk of developing	53
autologous hematopoietic stem	53
was added to	53
to declare p	53
from peripheral blood	53
at high risk	53
donors in the	53
of platelet concentrates	53
to develop a	53
to estimate the	53
and has been	53
to respond to	53
characteristics of the	53
the field of	53
shown in the	53
presence of the	53
copyright holder for	52
binding to the	52
were no differences	52
may be associated	52
has the potential	52
disease free survival	52
the beginning of	52
low levels of	52
this version posted	52
data from the	52
option for patients	52
of morbidity and	52
to be an	52
results demonstrate that	52
at a dose	52
of the protein	52
high dose chemotherapy	52
and treatment of	52
it is also	52
high incidence of	52
in the field	52
with a mean	52
t cell repertoire	52
the range of	52
infection in the	52
were compared with	52
to ensure that	52
this preprint this	52
was a significant	52
for this preprint	52
followed by autologous	52
preprint this version	52
blood group antigens	52
holder for this	52
and function of	52
matched sibling donor	52
cell responses in	52
limited number of	52
activity of the	52
correlated with the	52
of children with	52
at risk of	51
t cell depletion	51
pediatric patients with	51
at risk for	51
been shown that	51
memory t cell	51
in the graft	51
the patient had	51
patients with relapsed	51
after lung transplantation	51
of the peptides	51
may be due	51
hemolytic transfusion reactions	51
the study is	51
abo blood group	51
of the procedure	51
mesenchymal stem cells	51
test was used	51
which is a	51
and in patients	51
blood components and	51
revealed that the	51
in this context	51
the blood donors	51
to test the	51
were more likely	51
was due to	51
in the s	51
standard of care	51
was based on	51
the start of	51
that have been	51
peptides derived from	51
we demonstrate that	50
with an increased	50
matched unrelated donors	50
on the contrary	50
matched related donor	50
complex class i	50
results in a	50
in univariate analysis	50
and one patient	50
the fi rst	50
were performed on	50
than that of	50
were performed with	50
on day after	50
blood donors were	50
in both the	50
in the patient	50
our results show	50
had to be	50
allogeneic bone marrow	50
course of the	50
used to determine	50
mean age of	50
were transplanted in	50
bone marrow in	50
one patient died	50
white blood cells	50
is mediated by	50
were measured by	50
did not receive	50
and nk cells	50
impact of the	50
which could be	50
the initiation of	50
of these cells	50
the interaction between	50
was analyzed by	49
and cord blood	49
in the following	49
progression free survival	49
and number of	49
days of storage	49
the primary endpoint	49
are known to	49
and development of	49
of the four	49
a risk factor	49
function of the	49
the incidence and	49
in bone marrow	49
from unrelated donors	49
and mortality in	49
a diagnosis of	49
up was months	49
in a cohort	49
a mean of	49
of the s	49
cells as well	49
of the different	49
was not significantly	49
was evaluated by	49
year cumulative incidence	49
one patient with	49
donor t cells	49
the mean age	49
dependent on the	49
for these patients	49
of patients was	49
similar to that	49
and should be	49
was identified in	49
study of the	49
of b cells	49
the evaluation of	49
results showed that	49
to characterize the	49
the extent of	49
peripheral blood of	49
a significant difference	49
were excluded from	48
have also been	48
associated with high	48
and months after	48
to be more	48
and cd cd	48
os and pfs	48
from an hla	48
is thought to	48
a statistically significant	48
gvhd prophylaxis was	48
we compared the	48
were subjected to	48
it is a	48
well as a	48
for prediction of	48
cell epitopes in	48
cell response to	48
bacterial contamination of	48
cell transplantation is	48
the group with	48
be used in	48
the interaction of	48
the need to	48
gvhd prophylaxis consisted	48
clinical trial registry	48
when compared with	48
of which were	48
of the anti	48
time of the	48
in the regulation	48
cells and the	48
in our institution	48
at last follow	48
in the plasma	48
a year old	48
the median duration	48
are alive and	48
allogeneic haematopoietic stem	48
performed in patients	48
of more than	48
adaptive immune responses	48
caused by the	48
an unrelated donor	48
high risk patients	48
thought to be	48
of the rhd	48
specific cytotoxic t	48
we showed that	47
was not statistically	47
the collection of	47
of the host	47
in recipients of	47
regimen consisted of	47
to those of	47
during the course	47
of b cell	47
blood donation and	47
response to a	47
it is known	47
intensity conditioning regimen	47
at transplant was	47
a role for	47
acute gvhd and	47
we examined the	47
only one patient	47
as compared with	47
and cd cell	47
in group a	47
with the median	47
whole blood donors	47
of the national	47
with a higher	47
patients with hematological	47
are present in	47
depends on the	47
resulted in the	47
in the liver	47
required for the	47
the efficiency of	47
status of the	47
and after the	47
did not affect	47
in the peripheral	47
can be a	46
is needed to	46
the first step	46
in this patient	46
we demonstrated that	46
only in the	46
efficacy of the	46
and management of	46
the source of	46
were performed by	46
p r o	46
with an average	46
the volume of	46
transplantation in patients	46
of graft failure	46
t cell immunity	46
in patients treated	46
with the exception	46
higher in patients	46
levels of the	46
incidence of grade	46
there has been	46
the increase in	46
center background case	46
herpes simplex virus	46
results in the	46
we suggest that	46
analysis showed that	46
cells can be	46
with bone marrow	46
was applied to	46
the in vivo	46
for blood donation	46
be explained by	46
in the period	46
to donate blood	46
of blood group	46
prior to hsct	46
that may be	46
for the same	46
in the diagnosis	46
the determination of	46
found to have	46
months after hsct	46
in the human	46
stem cell mobilization	46
the innate immune	46
has been suggested	46
is not a	46
that could be	46
both cd and	46
reduction in the	46
stored for days	46
with a low	46
have demonstrated that	46
of the clinical	46
haploidentical stem cell	46
had no effect	46
is safe and	46
of grade ii	45
conditioning regimen consisted	45
increased expression of	45
colony stimulating factor	45
are required to	45
in the transfusion	45
and type of	45
in this group	45
has been demonstrated	45
class i binding	45
the major histocompatibility	45
hemolytic disease of	45
stem cells in	45
the frequencies of	45
we sought to	45
at this time	45
the current study	45
the mhc i	45
the remaining patients	45
the basis for	45
the result of	45
the median of	45
fludarabine mg m	45
of the fetus	45
carried out by	45
of red cells	45
our results suggest	45
on days and	45
to be used	45
for gvhd prophylaxis	45
these results indicate	45
the establishment of	45
follow up was	45
the results obtained	45
months after the	45
sequence of the	45
indirect antiglobulin test	45
this work was	45
more common in	45
conditioning regimen for	45
chronic granulomatous disease	45
were defined as	45
epitopes in the	45
to prevent the	44
used to identify	44
may also be	44
was significantly associated	44
by using the	44
in the current	44
blood samples from	44
and the presence	44
have been found	44
the cd cd	44
were present in	44
and the use	44
patients affected by	44
amino acid sequence	44
performed on the	44
risk of transfusion	44
similar to those	44
higher than the	44
patients who developed	44
the exception of	44
to our knowledge	44
of acute and	44
that in the	44
a safe and	44
x cd cells	44
in most cases	44
a review of	44
in vivo and	44
cd cells in	44
time of transplant	44
peripheral blood in	44
higher levels of	44
in t cells	44
with acute leukemia	44
the prediction of	44
the need of	44
the mechanisms of	44
with acute myeloid	44
determined by the	44
is used to	44
h n influenza	44
blood transfusion is	44
significant difference was	44
high rate of	44
the appearance of	44
characterized by a	44
was designed to	44
of the cell	44
and in vitro	44
year os was	43
of class i	43
the presence or	43
t cells by	43
e l l	43
due to anti	43
is shown in	43
immunodeficiency virus type	43
and b cell	43
of the three	43
the capacity to	43
in the lung	43
findings suggest that	43
neutrophil engraftment was	43
review of the	43
were evaluated for	43
may be an	43
was not associated	43
should not be	43
at least two	43
in the management	43
months after transplantation	43
in our experience	43
has been described	43
the blood donation	43
class i mhc	43
peripheral blood and	43
by t cells	43
were identified in	43
the nature of	43
in the production	43
ministry of health	43
that the use	43
patients with active	43
is important for	43
for blood transfusion	43
cd cd cells	43
we have shown	43
no difference between	43
in the thymus	43
inflammatory bowel disease	43
one of them	43
for use in	43
red cell units	43
the serum of	43
we present a	43
of the antigen	43
over the last	43
were incubated with	43
time from diagnosis	43
significant reduction of	43
in adult patients	43
to the patient	43
and could be	43
patients with mm	43
is related to	43
and use of	43
in one case	43
treatment option for	43
the amino acid	43
reactive t cells	43
and severity of	43
cyclophosphamide mg kg	43
national blood transfusion	43
university school of	43
is to evaluate	43
processing and presentation	43
for detection of	43
in the course	43
wide range of	43
leads to the	43
high frequency of	43
factors such as	42
quality of blood	42
p r e	42
in the hla	42
treatment of patients	42
effector t cells	42
t cell lines	42
as measured by	42
basis of the	42
it was shown	42
it should be	42
tests were performed	42
patients with sle	42
the patients received	42
higher number of	42
red cell concentrates	42
class i alleles	42
the dose of	42
in patients after	42
world health organization	42
response in the	42
the choice of	42
on day of	42
with a history	42
blood and marrow	42
may play a	42
regulation of the	42
presence of anti	42
in this setting	42
development of the	42
of the vaccine	42
as an alternative	42
pre and post	42
supported by the	42
vg vd t	42
in the population	42
in the t	42
in the spleen	42
reported in the	42
is dependent on	42
in the induction	42
cells specific for	42
t cells specific	42
was obtained from	42
during the period	42
the results are	42
a consequence of	42
the size of	42
to measure the	42
there have been	42
of the hiv	42
this may be	42
overall survival in	42
comparison of the	42
safety of the	42
the kinetics of	41
in the clinical	41
has been developed	41
patients did not	41
free survival was	41
these results demonstrate	41
in the process	41
overall survival and	41
size of the	41
the efficacy and	41
patients have been	41
an attempt to	41
were selected for	41
the length of	41
the patients had	41
and the mean	41
binding to mhc	41
patient blood management	41
period of time	41
was lower in	41
the sensitivity of	41
engraftment was days	41
was found that	41
with the highest	41
of the newborn	41
positive for anti	41
in our cohort	41
goal of this	41
melphalan mg m	41
were measured in	41
primary graft failure	41
due to its	41
the value of	41
levels of cd	41
donors with a	41
is responsible for	41
autologous peripheral blood	41
on behalf of	41
and identification of	41
study was performed	41
of all the	41
as early as	41
was detected by	41
at the moment	41
in blood transfusion	41
in our centre	41
been observed in	41
cd cell count	41
of the recipient	41
data were collected	41
car t cells	41
the ratio of	41
the concept of	41
were enrolled in	41
a critical role	41
determination of the	41
at the beginning	41
of the other	41
was the only	41
of patients receiving	41
used to evaluate	41
kg body weight	41
treated with a	41
in more than	40
related or unrelated	40
expressed on the	40
memory b cells	40
of patients are	40
cells and cd	40
have been observed	40
for children with	40
have developed a	40
well as to	40
the existence of	40
were due to	40
secondary graft failure	40
blood donors with	40
contrast to the	40
blood donors is	40
serum levels of	40
to present the	40
is used for	40
in this cohort	40
the class i	40
the presentation of	40
cd or cd	40
more frequent in	40
all patients engrafted	40
which has been	40
the difference between	40
immune response and	40
diffuse large b	40
activated t cells	40
over a period	40
severe chronic gvhd	40
a part of	40
is capable of	40
ranging from to	40
was found between	40
is defined as	40
c e l	40
were analyzed for	40
demonstrate that the	40
serve as a	40
that it is	40
in our series	40
o u r	40
is used in	40
on the use	40
the discovery of	40
may have a	40
at least in	40
with hematological malignancies	40
to elucidate the	40
epitopes of the	40
patients with an	40
to be involved	40
and h n	40
of the conditioning	40
cytotoxic t cell	40
increased susceptibility to	40
patients undergoing allogeneic	40
the national blood	40
of infectious diseases	40
and that the	40
independently associated with	40
one patient had	40
blood donors who	40
surface of the	40
the most commonly	40
group and in	40
shown that the	40
in the a	40
of the following	40
a trend towards	40
cause of morbidity	40
of the present	40
a is the	40
in the uk	40
after hematopoietic stem	40
of a new	40
results of a	40
performed a retrospective	40
was diagnosed with	40
of death were	40
of overall survival	40
of the use	39
antibodies in the	39
been implicated in	39
the red cell	39
the most frequently	39
ifitm double null	39
patients diagnosed with	39
cell activation and	39
for min at	39
of the a	39
expression in the	39
we have recently	39
platelet engraftment was	39
and had a	39
differences were observed	39
compared to non	39
respect to the	39
among the patients	39
were added to	39
was peripheral blood	39
of the data	39
is required to	39
is a significant	39
are likely to	39
was not observed	39
in the general	39
seen in the	39
divided into two	39
the contribution of	39
have been associated	39
essential for the	39
were similar in	39
of the ebmt	39
cell epitopes of	39
of the new	39
has been observed	39
compared to a	39
a marker of	39
a l p	39
t cells is	39
in severe covid	39
r n a	39
the success of	39
of the viral	39
we used a	39
class i antigens	39
are required for	39
units of blood	39
components of the	39
ifitm ifitm double	39
at months after	39
for the prevention	39
were identified as	39
the vast majority	39
to better understand	39
do not have	39
the maintenance of	39
due to their	39
not differ between	39
distribution of the	39
the central nervous	39
of a single	39
who underwent allogeneic	39
nk cells in	39
statistical analysis was	39
in patients without	39
similar in both	39
were not significantly	39
hsct in our	39
to ensure the	39
to detect the	39
from blood donors	39
after allogeneic hsct	39
the potential of	39
vast majority of	39
we used the	39
of cmv reactivation	39
plays an important	39
class i molecule	39
isolated from the	39
responses to the	39
for each of	39
in those with	39
immune responses in	39
adverse events were	39
from the blood	39
for the entire	39
some of these	39
most of them	38
american red cross	38
from bone marrow	38
days after hsct	38
main cause of	38
approved by the	38
the risk for	38
patients with the	38
immune response against	38
may be used	38
a matched unrelated	38
of them had	38
chronic gvhd and	38
patients transplanted from	38
in two patients	38
which was not	38
therapy in patients	38
over the past	38
t cell recognition	38
the site of	38
characterization of the	38
chronic graft versus	38
the spike protein	38
at the university	38
we developed a	38
of cmv infection	38
for the study	38
and days after	38
together with the	38
increased in the	38
shown in fig	38
the most effective	38
the donor was	38
were transplanted from	38
to play a	38
of the samples	38
in the non	38
with the aim	38
gvhd grade ii	38
patients with advanced	38
may result in	38
the reduction of	38
kidney transplant recipients	38
human t cell	38
were cultured in	38
the host immune	38
as in the	38
to the mhc	38
but also in	38
in the multivariate	38
adoptive transfer of	38
high density multiepitope	38
while in the	38
patients with agvhd	38
epitopes derived from	38
in blood and	38
after stem cell	38
of immune responses	38
was positive in	38
were collected and	38
of the il	38
this suggests that	38
in some patients	38
was to analyze	38
we have identified	38
to enhance the	38
for the diagnosis	38
of patients received	38
of cd b	38
linked to the	38
common cause of	38
who underwent allo	38
on the outcome	38
significantly lower than	38
the transfusion of	38
in a dose	38
as a potential	38
study aimed to	38
amino acid sequences	37
was to compare	37
voluntary blood donors	37
of the liver	37
were identified by	37
these patients were	37
is not known	37
survival in patients	37
using flow cytometry	37
significantly different between	37
r o o	37
to explore the	37
innate immune system	37
of adverse events	37
conditioning regimens were	37
a high level	37
is essential to	37
u r n	37
incidence of chronic	37
quality and safety	37
can be detected	37
frequency of the	37
relapsed or refractory	37
platelets stored at	37
cells in a	37
we hypothesize that	37
the samples were	37
this group of	37
is made available	37
a significant proportion	37
described in the	37
of a novel	37
in vitro studies	37
to validate the	37
the data of	37
by the presence	37
and with the	37
positive and negative	37
a key role	37
used to assess	37
by cd t	37
reported to the	37
patients who did	37
referred to as	37
mean number of	37
significant impact on	37
at the age	37
blood products and	37
to describe the	37
used in patients	37
most common cause	37
phase of the	37
l p r	37
mainly due to	37
change in the	37
results of this	37
the preparation of	37
donor lymphocyte infusion	37
is found in	37
a reduced intensity	37
the blood group	37
in the skin	37
of our patients	37
j o u	37
and the development	37
cd cells was	37
for the blood	37
we have been	37
as the most	37
based on this	37
predicted to be	37
and of patients	37
o o f	37
were evaluated by	37
chronic gvhd were	36
are presented in	36
on t cell	36
probably due to	36
has been identified	36
patients with covid	36
resulting in the	36
of the epitope	36
data demonstrate that	36
significant decrease in	36
response to treatment	36
the patients was	36
were shown to	36
primary and secondary	36
insights into the	36
in cases with	36
patients had received	36
compared to control	36
we studied the	36
compared to other	36
we tested the	36
and dendritic cells	36
used in this	36
the world health	36
less than of	36
and duration of	36
patients at risk	36
large numbers of	36
it is made	36
with the development	36
diseases such as	36
in the analysis	36
accordance with the	36
results from the	36
in cd t	36
renal transplant recipients	36
outcome of the	36
a wide range	36
who had received	36
of the results	36
the stability of	36
be effective in	36
and of them	36
showed a significant	36
the red blood	36
t cells can	36
significant proportion of	36
a source of	36
in the pre	36
mg m day	36
results were obtained	36
we report on	36
with an increase	36
binding affinity to	36
was higher than	36
a crucial role	36
we decided to	36
a member of	36
the risk factors	36
and adaptive immune	36
the characteristics of	36
with the hla	36
fold increase in	36
or in combination	36
scansystem tm platelet	36
to the cell	36
that did not	36
t cell subsets	36
age at hsct	36
of less than	36
clinically significant antibodies	36
a higher risk	36
tm platelet kit	36
sensitivity of the	36
in this population	36
of the antibody	36
we believe that	36
of autologous blood	36
of up to	36
percentage of cd	36
is known that	36
recognized by the	36
university medical center	36
in this analysis	36
in a multivariate	36
allowed us to	36
the form of	36
were negative for	36
whether or not	35
for blood and	35
to achieve a	35
many of the	35
the entire cohort	35
be an effective	35
was reported in	35
b and t	35
age of patients	35
than of the	35
along with the	35
the main cause	35
statistically significant differences	35
serious adverse events	35
testing was performed	35
higher than that	35
were analysed by	35
severity of the	35
the department of	35
and response to	35
a n t	35
but not the	35
cd cells from	35
blood group systems	35
validation of the	35
of the high	35
enrolled in the	35
in this retrospective	35
conditioning regimen and	35
one patient developed	35
were analyzed using	35
significant reduction in	35
were the most	35
transfusion medicine and	35
transplanted in cr	35
of the pts	35
may be the	35
order to evaluate	35
used to predict	35
autoimmune hemolytic anemia	35
performed according to	35
had a significantly	35
in at least	35
and stem cell	35
the immunogenicity of	35
there are two	35
of the world	35
been described in	35
with at least	35
whole blood units	35
of bacterial contamination	35
neonatal alloimmune thrombocytopenia	35
with more than	35
has resulted in	35
from a matched	35
for transfusion medicine	35
university hospital of	35
domain of the	35
and compared to	35
as a model	35
of hla alleles	35
autologous blood donation	35
the infusion of	35
these data indicate	35
mutation in the	35
considered as a	35
shows that the	35
chronic myeloid leukemia	35
we describe the	35
significant differences were	35
had a positive	35
the time to	35
among blood donors	35
distribution of blood	35
associated with lower	35
g dl and	35
high expression of	35
incidence of agvhd	35
t cells of	35
cord blood units	35
the patients in	35
in critically ill	35
an alternative to	35
by a single	35
have been performed	35
resulted in an	35
and the remaining	35
patients were enrolled	35
autologous and allogeneic	35
of relapse was	35
acute myeloid leukaemia	35
first time donors	35
of the infection	35
quality control of	35
blood donation is	35
indicated that the	35
the possibility that	35
were higher in	35
the adaptive immune	35
a significant decrease	35
information on the	35
on day was	35
bind to the	35
is also a	35
properties of the	35
of the d	35
is a well	35
of the main	35
of mice with	35
retrospective review of	35
up to years	35
overall survival of	35
of factor viii	35
the patient received	35
and activation of	35
be considered in	35
council of europe	35
to meet the	35
high degree of	34
that the number	34
average number of	34
by the use	34
therapeutic plasma exchange	34
regardless of the	34
focused on the	34
to the treatment	34
not seem to	34
overall response rate	34
derived from a	34
older than years	34
antigen processing and	34
a reduction of	34
of the whole	34
natural killer cells	34
for the generation	34
these results are	34
lilrb d d	34
conclude that the	34
nk cells and	34
observed that the	34
cd cells and	34
previous studies have	34
the significance of	34
or in the	34
in the post	34
the donors were	34
the past years	34
of the above	34
production of il	34
days after transplantation	34
to analyse the	34
in the form	34
the structure of	34
order to prevent	34
red cross blood	34
antigens in the	34
difference was found	34
of pts with	34
may be useful	34
peptide binding to	34
the proliferation of	34
high prevalence of	34
patients with refractory	34
a and hla	34
and with a	34
s and s	34
was a trend	34
by use of	34
donor lymphocyte infusions	34
length of stay	34
positive results were	34
with the presence	34
was similar in	34
mice immunized with	34
mobilized peripheral blood	34
single center experience	34
was observed with	34
international license it	34
a major cause	34
a myeloablative conditioning	34
work was supported	34
of relapse and	34
made available under	34
binding of the	34
no conflict of	34
and lack of	34
amino acid residues	34
can be achieved	34
under a is	34
of gvhd and	34
for all the	34
available under a	34
to have the	34
better understanding of	34
able to induce	34
to monitor the	34
compared with those	34
in the world	34
the t cells	34
license it is	34
treatment of the	34
the accumulation of	34
is expected to	34
in this work	34
to cd t	34
shown to have	34
increased risk for	34
stem cells from	34
especially in the	34
in our blood	34
of these two	34
delta t cells	34
determined to be	34
immune epitope database	34
and the patient	34
stem cells were	34
in group b	34
cd cd t	34
we have found	34
has shown that	34
all but one	34
found in patients	34
in the bone	34
and mhc class	34
duration of the	34
was observed between	34
abstract already published	34
not able to	34
for h at	34
the recognition of	33
cell proliferation and	33
time of days	33
of regulatory t	33
so as to	33
two patients with	33
blood products is	33
the reasons for	33
of units of	33
immune responses and	33
a prospective study	33
is similar to	33
has been proposed	33
each of these	33
and outcome of	33
stability of the	33
hsct in patients	33
in multiple myeloma	33
is not yet	33
the rest of	33
in of them	33
was confirmed in	33
cellular immune responses	33
is feasible and	33
the cord blood	33
abo and rh	33
focus on the	33
we are currently	33
occurred in the	33
has been the	33
the last decade	33
in the recipient	33
even in the	33
the fetus and	33
the difference in	33
of the plasma	33
according to their	33
time of transplantation	33
and treated with	33
of the method	33
were classified as	33
shown in figure	33
is a key	33
packed red blood	33
were screened for	33
can be found	33
is still a	33
was performed for	33
to the same	33
for the whole	33
developed acute gvhd	33
after bone marrow	33
these findings suggest	33
were transfused with	33
in patients transplanted	33
human papillomavirus type	33
the quality and	33
were in cr	33
in the whole	33
study shows that	33
did not reach	33
donors and recipients	33
children and adolescents	33
was well tolerated	33
indicates that the	33
for t cell	33
treatment related mortality	33
of t lymphocytes	33
significantly increased in	33
was also observed	33
of cases of	33
outcomes of patients	33
who underwent hsct	33
was performed at	33
mg kg d	33
the multivariate analysis	33
for the identification	33
objective was to	33
at day after	33
we describe a	33
for this purpose	33
evaluate the impact	33
were transplanted with	33
bone marrow cells	33
patients with hematologic	33
of hepatitis b	33
the expansion of	33
cov s protein	33
were tested by	33
we have used	33
were conditioned with	33
treated with the	33
of the current	33
residues in the	33
after blood donation	33
for cd t	33
could be detected	33
none of them	33
with a positive	33
risk of graft	33
in clinical practice	33
effects of the	33
cells with a	33
had a significant	33
conducted a retrospective	33